Skip to main content

Advertisement

Log in

The computed tomography adrenal wash-out analysis properly classifies cortisol secreting adrenocortical adenomas

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Purpose

Adrenocortical lesions are characterized through imaging, hormonal and histopathological analysis. Our aim was to compare the radiological features of adrenocortical lesions with their cortisol-secreting status and histopathological Weiss score.

Methods

Seventy five patients operated between 2004 and 2016 in the University Hospital of Nancy for either adrenocortical carcinomas (ACC) or adrenocortical adenomas (ACA) were enrolled in this study. We collected cortisol parameters, Computed Tomography (CT) scans (unenhanced density, wash-out (WO) analysis) and 18F-Fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) datas. The histopathological Weiss score ultimately differentiates ACA (score ≤ 2) from ACC (score ≥ 3). One-way ANOVA, Fisher’s exact and unpaired t tests were used for statistical analysis with significancy reached at p < 0.05.

Results

There were 23 ACC and 52 ACA with 40 patients (53%) who had an autonomous secretion of cortisol. On CT scan, ACC were larger compared to ACA (108 vs. 37 mm, p < 0.0001). A roughly similar proportion of cortisol-secreting (22/25) and non-secreting (15/19) ACA were atypical (i.e., unenhanced density value ≥ 10 Hounsfield Units [HU]), however 85% of cortisol-secreting vs. 40% of non-secreting ACA were classified as benigns by the relative WO analysis (p = 0.08). Likewise, there was a trend for a higher 18F-FDG uptake in cortisol-secreting ACA compared to non-secreting ACA (p = 0.053).

Conclusions

The relative adrenal WO analysis consolidates the benign nature of an ACA, especially in case of cortisol oversecretion, a condition known to compromise the diagnostic accuracy of the 10 HU unenhanced CT attenuation threshold.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. J.H. Song, F.S. Chaudhry, W.W. Mayo-Smith, The incidental adrenal mass on CT: Prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. Am. J. Roentgenol. 190, 1163–1168 (2008)

    Article  Google Scholar 

  2. W.F. Young, Clinical practice. The incidentally discovered adrenal mass. N. Engl. J. Med. 356, 601–610 (2007).

    Article  CAS  Google Scholar 

  3. M. Terzolo, A. Stigliano, I. Chiodini, P. Loli, L. Furlani, G. Arnaldi, G. Reimondo, A. Pia, V. Toscano, M. Zini, G. Borretta, E. Papini, P. Garofalo, B. Allolio, B. Dupas, F. Mantero, A. Tabarin, AME position statement on adrenal incidentaloma. Eur. J. Endocrinol. 164, 851–870 (2011)

    Article  CAS  Google Scholar 

  4. A. Frilling, K. Tecklenborg, F. Weber, H. Kühl, S. Müller, G. Stamatis, C. Broelsch, Importance of adrenal incidentaloma in patients with a history of malignancy. Surgery 136, 1289–1296 (2004)

    Article  Google Scholar 

  5. M. Fassnacht, W. Arlt, I. Bancos, H. Dralle, J. Newell-Price, A. Sahdev, A. Tabarin, M. Terzolo, S. Tsagarakis, O.M. Dekkers, Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol. 175, G1–G34 (2016)

    Article  CAS  Google Scholar 

  6. J.H. Song, D.J. Grand, M.D. Beland, K.J. Chang, J.T. Machan, W.W. Mayo-Smith, Morphologic features of 211 adrenal masses at initial contrast-enhanced CT: can we differentiate benign from malignant lesions using imaging features alone? Ajr. Am. J. Roentgenol. 201, 1248–1253 (2013)

    Article  Google Scholar 

  7. A. Sahdev, J. Willatt, I.R. Francis, R.H. Reznek, The indeterminate adrenal lesion. Cancer Imaging 10, 102–113 (2010)

    Article  Google Scholar 

  8. C. Chambre, E. McMurray, C. Baudry, M. Lataud, L. Guignat, S. Gaujoux, N. Lahlou, J. Guibourdenche, F. Tissier, M. Sibony, B. Dousset, X. Bertagna, J. Bertherat, P. Legmann, L. Groussin, The 10 Hounsfield units unenhanced computed tomography attenuation threshold does not apply to cortisol secreting adrenocortical adenomas. Eur. J. Endocrinol. 173, 325–332 (2015)

    Article  CAS  Google Scholar 

  9. M.A. Blake, M.K. Kalra, A.T. Sweeney, B.C. Lucey, M.M. Maher, D.V. Sahani, E.F. Halpern, P.R. Mueller, P.F. Hahn, G.W. Boland, Distinguishing Benign from Malignant Adrenal Masses: Multi–Detector Row CT Protocol with 10-Minute Delay 1. Radiology 238, 578–585 (2006)

    Article  Google Scholar 

  10. C.S. Peña, G.W. Boland, P.F. Hahn, M.J. Lee, P.R. Mueller, Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology 217, 798–802 (2000)

    Article  Google Scholar 

  11. L. Groussin, G. Bonardel, S. Silvéra, F. Tissier, J. Coste, G. Abiven, R. Libé, M. Bienvenu, J.-L. Alberini, S. Salenave, P. Bouchard, J. Bertherat, B. Dousset, P. Legmann, B. Richard, H. Foehrenbach, X. Bertagna, F. Tenenbaum, 18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients. J. Clin. Endocrinol. Metab. 94, 1713–1722 (2009)

    Article  CAS  Google Scholar 

  12. C. Guerin, F. Pattou, L. Brunaud, J.-C. Lifante, E. Mirallié, M. Haissaguerre, D. Huglo, P. Olivier, C. Houzard, C. Ansquer, E. Hindié, A. Loundou, C. Archange, A. Tabarin, F. Sebag, K. Baumstarck, D. Taïeb, Performance of 18F-FDG PET/CT in the characterization of adrenal masses in noncancer patients: a prospective study. J. Clin. Endocrinol. Metab. 102, 2465–2472 (2017)

    Article  Google Scholar 

  13. G.W.L. Boland, B.A. Dwamena, M. Jagtiani Sangwaiya, A.G. Goehler, M.A. Blake, P.F. Hahn, J.A. Scott, M.K. Kalra, Characterization of adrenal masses by using FDG PET: a systematic review and meta-analysis of diagnostic test performance. Radiology 259, 117–126 (2011)

    Article  Google Scholar 

  14. L.M. Weiss, Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am. J. Surg. Pathol. 8, 163–169 (1984)

    Article  CAS  Google Scholar 

  15. M. Korobkin, T.J. Giordano, F.J. Brodeur, I.R. Francis, E.S. Siegelman, L.E. Quint, N.R. Dunnick, J.P. Heiken, H.H. Wang, Adrenal adenomas: relationship between histologic lipid and CT and MR findings. Radiology 200, 743–747 (1996)

    Article  CAS  Google Scholar 

  16. E.M. Caoili, M. Korobkin, I.R. Francis, R.H. Cohan, N.R. Dunnick, Delayed enhanced CT of lipid-poor adrenal adenomas. Am. J. Roentgenol. 175, 1411–1415 (2000)

    Article  CAS  Google Scholar 

  17. B.K. Park, B. Kim, K. Ko, S.Y. Jeong, G.Y. Kwon, Adrenal masses falsely diagnosed as adenomas on unenhanced and delayed contrast-enhanced computed tomography: Pathological correlation. Eur. Radiol. 16, 642–647 (2006)

    Article  Google Scholar 

  18. A. Kutikov, K. Mallin, D. Canter, Y.-N. Wong, R.G. Uzzo, Effects of increased cross sectional imaging on the diagnosis and prognosis of adrenocortical carcinoma: analysis of the national cancer data base. J. Urol. 186, 805–810 (2011)

    Article  Google Scholar 

  19. T.M.A. Kerkhofs, R.H.A. Verhoeven, J.M. Van der Zwan, J. Dieleman, M.N. Kerstens, T.P. Links, L.V. Van, de Poll-Franse, H.R. Haak, Adrenocortical carcinoma: a population-based study on incidence and survival in the Netherlands since 1993. Eur. J. Cancer 49, 2579–2586 (2013)

    Article  Google Scholar 

  20. A.O. Ciftci, M.E. Şenocak, F.C. Tanyel, N. Büyükpamukçu, Adrenocortical tumors in children. J. Pediatr. Surg. 36, 549–554 (2001)

    Article  CAS  Google Scholar 

  21. T. Kerkhofs, M. Ettaieb, R. Verhoeven, G. Kaspers, W. Tissing, J. Loeffen, M. Van den Heuvel-Eibrink, R. De Krijger, H. Haak, Adrenocortical carcinoma in children: First population‑based clinicopathological study with long-term follow-up. Oncol. Rep. 32, 2836–2844 (2014)

    Article  CAS  Google Scholar 

  22. D. Patel, S.K. Gara, R.J. Ellis, M. Boufraqech, N. Nilubol, C. Millo, C.A. Stratakis, E. Kebebew, FDG PET/CT scan and Ffnctional adrenal tumors: a pilot study for lateralization. World J. Surg. 40, 683–689 (2016)

    Article  Google Scholar 

  23. N. Jin, W. Qian, X. Yin, L. Zhang, K. Iqbal, I. Grundke-Iqbal, C.-X. Gong, F. Liu, CREB regulates the expression of neuronal glucose transporter 3: a possible mechanism related to impaired brain glucose uptake in Alzheimer's disease. Nucleic Acids Res. 41, 3240–3256 (2013)

    Article  CAS  Google Scholar 

  24. F. Beuschlein, M. Fassnacht, G. Assié, D. Calebiro, C.A. Stratakis, A. Osswald, C.L. Ronchi, T. Wieland, S. Sbiera, F.R. Faucz, K. Schaak, A. Schmittfull, T. Schwarzmayr, O. Barreau, D. Vezzosi, M. Rizk-Rabin, U. Zabel, E. Szarek, P. Salpea, A. Forlino, A. Vetro, O. Zuffardi, C. Kisker, S. Diener, T. Meitinger, M.J. Lohse, M. Reincke, J. Bertherat, T.M. Strom, B. Allolio, Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome. N. Engl. J. Med. 370, 1019–1028 (2014)

    Article  CAS  Google Scholar 

  25. D. Calebiro, G. Di Dalmazi, K. Bathon, C.L. Ronchi, F. Beuschlein, cAMP signaling in cortisol-producing adrenal adenoma. Eur. J. Endocrinol. 173, M99–M106 (2015)

    Article  CAS  Google Scholar 

  26. G. Di Dalmazi, R. Pasquali, F. Beuschlein, M. Reincke, Subclinical hypercortisolism: a state, a syndrome, or a disease? Eur. J. Endocrinol. 173, M61–M71 (2015)

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Thomas Cuny.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Humbert, AL., Lecoanet, G., Moog, S. et al. The computed tomography adrenal wash-out analysis properly classifies cortisol secreting adrenocortical adenomas. Endocrine 59, 529–537 (2018). https://doi.org/10.1007/s12020-018-1522-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-018-1522-7

Keywords

Navigation